tm logo
RELTRIPVEE
Live/Pending
NOTICE OF ALLOWANCE - ISSUED

issued

on 16 Jul 2024

Last Applicant/ Owned by

Zieglerstrasse 6

Aachen

DE

52078

Serial Number

98133621 filed on 15th Aug 2023

Registration Number

N/A

Correspondent Address

Alexander Reid

ALEXANDER REID WISSING MILLER LLP

INDUSTRIOUS AT HUDSON YARDS

NEW YORK, NY 10001

UNITED STATES

Filing Basis

1. intent to use

2. intent to use current

Disclaimer

NO DATA

RELTRIPVEE

Pharmaceuticals, namely, pharmaceutical preparations for the treatment of osteoarthritis, rheumatoid arthritis, diabetic neuropathy, peripheral neuropathy, small fiber neuropathy, trigeminal neuralgia, post herpetic neuralgia, post amputation neuropathic pain, post operative pain, cancer-related pain, trigger point pain, sciatica, overactive bladder syndrome, fibromyalgia syndrome, erythromelalgia Read More

Classification Information


Class [005]
Pharmaceutical Products


Pharmaceuticals, namely, pharmaceutical preparations for the treatment of osteoarthritis, rheumatoid arthritis, diabetic neuropathy, peripheral neuropathy, small fiber neuropathy, trigeminal neuralgia, post herpetic neuralgia, post amputation neuropathic pain, post operative pain, cancer-related pain, trigger point pain, sciatica, overactive bladder syndrome, fibromyalgia syndrome, erythromelalgia; medical preparations for the treatment of pain; sanitary preparations for medical purposes


First Use Date in General

N/A

First Use Date in Commerce

N/A

Mark Details


Serial Number

No 98133621

Mark Type

No Service/Collective Mark

Attorney Docket Number

No 516-0004

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Status DateAction Taken
16th Jul 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
21st May 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
21st May 2024PUBLISHED FOR OPPOSITION
01st May 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
17th Apr 2024APPROVED FOR PUB - PRINCIPAL REGISTER
15th Apr 2024ASSIGNED TO EXAMINER
13th Sep 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
18th Aug 2023NEW APPLICATION ENTERED